Portal vein thrombosis and liver transplantation: management, matching, and outcomes: a retrospective multicenter cohort study
Fabrizio Di Benedetto,Paolo Magistri,Stefano Di Sandro,Riccardo Boetto,Francesco Tandoi,Stefania Camagni,Andrea Lauterio,Duilio Pagano,Daniele Nicolini,Paola Violi,Daniele Dondossola,Nicola Guglielmo,Vittorio Cherchi,Quirino Lai,Luca Toti,Marco Bongini,Samuele Frassoni,Vincenzo Bagnardi,Vincenzo Mazzaferro,Giuseppe Tisone,Massimo Rossi,Umberto Baccarani,Giuseppe Maria Ettorre,Lucio Caccamo,Amedeo Carraro,Marco Vivarelli,Salvatore Gruttadauria,Luciano De Carlis,Michele Colledan,Renato Romagnoli,Umberto Cillo
DOI: https://doi.org/10.1097/js9.0000000000001149
2024-03-04
International Journal of Surgery
Abstract:Background and aims: Besides the increased risk of perioperative morbidity, graft failure, and mortality, the majority of PVT are diagnosed at liver transplantation (LT). Improving preoperative management and patient selection may lead to better short-term and long-term outcomes and reduce the risk of a futile LT. The authors aimed to identify predictors of adverse outcomes after LT in patients with nonmalignant portal vein thrombosis (PVT) and improve donor to recipient matching by analyzing the results of the Italian cohort of LT recipients. Methods: Adult patients who underwent LT in Italy between January 2000 and February 2020 diagnosed with PVT pre-LT or at time of LT were considered eligible for inclusion. Based on a survey encompassing all 26 surgeons participating in the study, a binary composite outcome was defined. Patients were classified as having the composite event if at least one of these conditions occurred: operative time more than 600 min, estimated blood loss greater than 5000 ml, more than 20 ICU days, 90 days mortality, 90 days retransplant. Results: Seven hundred fourteen patients were screened and 698 met the inclusion criteria. The analysis reports the results of 568 patients that fulfilled the criteria to enter the composite outcome analysis. Overall, 156 patients (27.5%) developed the composite outcome. PVT stage 3/4 at transplant and need for any surgical correction of PVT are independent predictors of the composite outcome occurrence. When stratified by PVT grade, overall survival at 1-year ranges from 89.0% with PVT grade 0/1 to 67.4% in patients with PVT grade 3/4 at LT ( P <0.001). Nevertheless, patients with severe PVT can improve their survival when identified risk factors are not present. Conclusions: Potential LT candidates affected by PVT have a benefit from LT that should be adequately balanced on liver function and type of inflow reconstruction needed to mitigate the incidence of adverse events. Nonetheless, the absence of specific risk factors may improve the outcomes even in patients with PVT grades 3–4.
surgery